Clinical Trials Browser

Phase 3 × INDUSTRY × talabostat × Clear all

NCT00290017 2007-06-08

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms